Peter Lehmann reviews the contribution of antipsychotics to suicide and depression in schizophrenia in the current International Journal of Psychotherapy. Publications about the intrinsic effects of antipsychotics on suicidality – which are “currently taboo,” he says – might reduce suicides in ‘schizophrenics.’ He suggests that a suicide register (akin to the mortality registers used in the medical field to identify connections between reduced life-expectancy and the outcomes of medical treatments) would meaningfully identify and lower the rate of suicide in people with emotional problems.
International Journal of Psychotherapy: 2012, Vol. 16, No 1., pp. 30-49
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.